PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

Cancer cells with estrogen or progesterone hormone receptors can grow in response to those hormones. When tumors are human epidermal growth factor receptor 2-negative (HER2-), they contain few to no ...

hypokalemia or QT prolongation – serious adverse events that can arise in patients taking currently approved medications – ...

It would be short-sided, erroneous and dangerous to think ill of mifepristone, which has several important applications,, M.D ...

Estrogen and progesterone combined in OCs act in a synergistic ... androgenic effect by their linkage with the androgenic receptor. On the other hand, progestins counter the beneficial estrogen ...

New postpartum depression findings could lead to a blood test to identify women at risk and possibly even to a preventive treatment. New postpartum depression research from the University of ...

At low doses it blocks the naturally occurring hormone progesterone from binding to its receptor in the body. This is one of the mechanisms by which it has been used in abortion care, as it blocks ...